Skip to main content
Equibles

MORGAN STANLEY

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 895421 NEW YORK, NY
Back to VTGN Full portfolio

Position in VTGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$67
+$66 QoQ
Shares Held
298
+29700.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 48 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 56% Shared 0% None 44%

Common Shares in VTGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. VTGN ranks #496 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in VTGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $67 298
2026-03-31 $1 1
2025-12-31 $8,354 12,658
2025-09-30 $97,745 27,534
2025-06-30 $24,294 12,147
2025-03-31 $128,212 51,285
2024-12-31 $50,421 17,092
2024-09-30 $16,010 5,319
2024-06-30 $20,412 5,866
2024-03-31 $113,302 21,459
2023-12-31 $100,609 19,574
2023-09-30 $13,413 2,560
2023-06-30 $6,393 3,420
2023-03-31 $21,977 183,153
2022-12-31 $24,935 249,386
2022-09-30 $23,229 154,879
2022-06-30 $114,320 129,913
2022-03-31 $899,339 725,276
2021-12-31 $669,605 343,389
2021-09-30 $142,286 51,930
2021-06-30 $659,965 209,513
2021-03-31 $1,345,234 631,566
2020-12-31 $24,335 12,544
2020-09-30 $8,780 12,544
2020-06-30 $6,648 12,544
2020-03-31 $5,519 12,544